Argenta
Argenta is a global animal health and nutrition contract research, development, and manufacturing organization (CRO/CDMO) offering integrated molecule-to-market services across pre-clinical, clinical, regulatory, and commercial manufacturing for animal health, food, and feed companies.
- Company typePrivate
- Founded2006
- HeadquartersAuckland, New Zealand
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Argenta does
Argenta is a global contract research, development, and manufacturing organization (CRO/CDMO) dedicated exclusively to the animal health and nutrition industry. The company offers an integrated 'molecule to market' service model spanning pre-clinical studies, clinical development, regulatory affairs, product development, and commercial-scale manufacturing. Argenta operates four EMA and FDA GMP-approved manufacturing sites across three continents and produces over one billion doses of animal health pharmaceuticals annually across 125+ commercial products and 600+ SKUs. Its technology stack includes proprietary drug delivery platforms covering chew matrices, transdermal, dispersible granules, controlled-release microspheres, and controlled-release intraruminal capsules, alongside veterinary-specific electronic data capture (EDC) systems and AAALAC-accredited pre-clinical facilities across three locations with 45 ABSL-2 rooms.
The company generates revenue through project-based B2B contract services, targeting enterprise animal health companies (including the majority of the top 10 global animal health firms), food and feed companies, and adjacent nutrition segments spanning both companion animals and production animals. Distribution is direct enterprise sales with no third-party channel layer, and pricing is not publicly disclosed as engagements are tailored to client requirements. Argenta reports a 95% regulatory submission success rate across 500+ food and feed submissions and 50+ product registrations through FDA/CVM, EMA, and EFSA, and has been named S&P Global's Animal Health Award for Best Services Company five times in the past six years.
The corporate structure is anchored by Argenta Holdco Limited (UK-domiciled parent, ultimate holding company Argenta Topco Limited), with KKR as majority investor since November 2020 and additional capital from NovaQuest via a US$30 million product financing in May 2021. Since 2021, Argenta has executed a roll-up strategy, acquiring KLIFOVET (2021), Pen & Tec Consulting (2022), Ondax Scientific (2022), Midwest Veterinary Services (2023), and a Shawnee sterile fill-finish manufacturing site (2024). Leadership transitions in 2024-2025, including a new CEO (Matthew Stober, September 2025) and CFO (Alastair Hay, January 2024), have accompanied CRO platform realignment (January 2025) and US operations consolidation (December 2025).
Argenta firmographics
Firmographics- Name
- Argenta
- Legal name
- Argenta Holdco Limited
- Website
- https://argentaglobal.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Argenta is a global animal health and nutrition contract research, development, and manufacturing organization (CRO/CDMO) offering integrated molecule-to-market services across pre-clinical, clinical, regulatory, and commercial manufacturing for animal health, food, and feed companies.
- Ownership category
- akta.pro rank
Argenta industry classification
Industry- Product category
- Animal Health Contract Research, Development and Manufacturing Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Pharmaceutical Preparations (2834), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
- akta.pro secondary industries
- Clinical CROs (Phase I–IV) (HLAGAAAA), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)
Keywords
Where Argenta is headquartered
LocationHeadquarters
- HQ city
- Auckland
- HQ country
- New Zealand
- HQ region
- Oceania
Offices10 records
Markets served
Argenta business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Contract Research Services (CRO): Full-service contract research including pre-clinical studies, clinical studies, regulatory affairs, data management, biostatistics, and animal/human nutrition services. Revenue generated through project-based fees for research services.
- Contract Manufacturing Services (CMO): Manufacturing services including clinical trial supplies, full-scale registration batches, and commercial production. Producing and supplying 125+ different commercial products and 600+ different SKUs.
- Contract Development Services (CDO): Product development services including biological development, pharmaceutical development, method development, and technology transfer.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Argenta product offering
Product offeringCore offering
Argenta provides integrated contract research (CRO), contract development (CDO), and contract manufacturing (CMO) services for the animal health industry. Its offering covers pre-clinical and clinical studies, regulatory affairs, product development, and manufacturing of pharmaceutical and nutritional animal health products, supporting clients from molecule to market.
Product overview
Argenta is the world's only global animal health and nutrition contract research, development, and manufacturing organisation (CRO/CDMO), offering an integrated 'molecule to market' approach. The company provides three interconnected service pillars: Research Services (CRO) covering clinical studies, pre-clinical studies, regulatory affairs, animal and human nutrition, data management, and biostatistics; Manufacturing Services (CMO) including EMA/FDA GMP-approved facilities for commercial-scale production; and Product Development Services (CDO) encompassing biological, pharmaceutical, and method development. These core services are supported by proprietary drug delivery technology platforms (chew matrices, transdermal, dispersible granules, controlled-release microspheres, and intraruminal capsules), comprehensive regulatory services, and specialized solutions spanning opportunity assessment, proof of concept, early development, and clinical development. The company operates research sites in Germany, New Zealand, Spain, UK, and the US, with manufacturing facilities on three continents.
Differentiator
Problem solved
Functional benefit
Products and services
- Contract Research (CRO) Services
- Contract Manufacturing (CMO) Services
- Contract Development (CDO) Services
- Regulatory Affairs Services
- Data Management and Biostatistics Services
- Animal and Human Nutrition Regulatory Services
- Pre-Clinical Studies
- Clinical Development Services
Quantifiable outcome
- 50+ product registrations through FDA/CVM, EMA, and EFSA
- +5 more outcomes
Companies that use Argenta
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles2 records
Argenta technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Argenta partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- IPIFF (International Platform of Insects for Food and Feed)coreStrategic collaboration to accelerate innovation in insect-based animal health and nutrition products and human nutrition products. IPIFF represents the insect production sector at EU level.
- Pentec ConsultingminorFood and feed regulatory consulting partnership referenced in services - Argenta recommends Pentec Consulting for specialized services.
- Midwest Veterinary Services (MVS)coreAcquired MVS to strengthen clinical research capabilities. MVS operates as part of Argenta's US CRO operations.
Scale indicators12 records
Recent moves9 records
Expansion highlights6 records
Argenta competitors and assessment
Company assessmentEmerging players
- Ceva Santé Animale: Fast-growing global animal health pharmaceutical company with internal CDMO-style capabilities. Comparable in vertical focus and customer overlap, though Ceva is primarily a product company expanding into biologics manufacturing.
Broad incumbents
- Elanco Animal Health: Global animal health company with internal manufacturing and R&D. Both customer of Argenta and operator of parallel CDMO-style capabilities; co-invested with Argenta in Stonehaven Incubate.
- Zoetis: World's largest animal health company with significant in-house manufacturing, R&D, and regulatory functions. Represents the largest class of Argenta's enterprise customers and the strategic benchmark for animal health services scale.
- Charles River Laboratories: Global CRO/CDMO serving both human and animal health research and manufacturing. Overlaps with Argenta on preclinical animal studies and contract manufacturing, though Charles River operates at much larger scale across the broader life sciences market.
- Labcorp (formerly Covance): Global CRO with animal health preclinical and clinical capabilities as part of a broader life sciences portfolio. Comparable to Argenta in clinical study design and data management but at much larger, diversified scale.
- Boehringer Ingelheim Animal Health: Major animal health pharmaceutical company with substantial in-house manufacturing and R&D. Significant customer overlap with Argenta and a comparable animal-health-only strategic orientation.
Others
- IDEXX Laboratories: Veterinary diagnostics and reference laboratory leader. Adjacent rather than directly competitive; shares the animal health end-market and overlapping customer base of veterinary practices.
- Phibro Animal Health: Animal health and nutrition company with internal development and manufacturing capabilities. Overlaps with Argenta in animal nutrition regulatory and CMC, though Phibro is primarily a product company rather than a service provider.
Direct peers
- Eurofins Scientific: Testing and contract services group with animal health and food/feed regulatory testing capabilities. Comparable to Argenta in regulatory affairs, food/feed submissions, and bioanalytical services supporting animal health customers.
- Triveritas: Veterinary regulatory consultancy and CRO focused on animal health product development. Directly comparable to Argenta's Klifovet-originated European regulatory and clinical offering for veterinary medicinal products.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Argenta social profiles
Digital presenceArgenta financial estimates
Financial estimateRevenue estimate
Valuation estimate
Argenta leadership team
Management profileNumber of profiles
Profiles18 records
Argenta subsidiaries and ownership
Company hierarchySubsidiaries14 records
Argenta funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Argenta M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Argenta
What does Argenta do?
Argenta provides integrated contract research (CRO), contract development (CDO), and contract manufacturing (CMO) services for the animal health industry. Its offering covers pre-clinical and clinical studies, regulatory affairs, product development, and manufacturing of pharmaceutical and nutritional animal health products, supporting clients from molecule to market.
Is Argenta a public or private company?
Argenta is a private company. It is classified as private equity controlled and is currently operating.
When was Argenta founded?
Argenta was founded in 2006. It employs 501 to 1,000 people.
Where is Argenta based?
Argenta is headquartered in Auckland, New Zealand, in the Oceania region.
How does Argenta make money?
Three revenue lines are on record. Contract Research Services (CRO) is the primary driver. The others are contract Manufacturing Services (CMO) and contract Development Services (CDO).
Who are Argenta's main competitors?
Ceva Santé Animale is listed as an emerging player. Broad incumbents are Elanco Animal Health, Zoetis, Charles River Laboratories, Labcorp (formerly Covance) and Boehringer Ingelheim Animal Health. Others are IDEXX Laboratories and Phibro Animal Health. Direct peers are Eurofins Scientific and Triveritas.
Does Argenta have an API?
No public API is recorded for Argenta.
What industry is Argenta in?
Argenta's product category is Animal Health Contract Research, Development and Manufacturing Services. Its primary akta.pro industry code is HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO, with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 5417 and its SIC code is 2834.